Oct. 10, 2025  — Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, LLC., has introduced the Collaborative Outcomes Registry for Evidence in Ventricular Arrhythmias (CORE-VA) during the International Symposium on Ventricular Arrhythmias in Philadelphia, Pennsylvania. The prospective, multicenter registry is designed to capture contemporary practice patterns in ventricular arrhythmia, including ventricular tachycardia (VT), ablation and generate high-quality real-world evidence.

Oct. 10, 2025 — Berlin Heals Holding AG, a clinical-stage medical device company focused on revolutionizing the care of heart failure with a first of its kind durable treatment, announced it has completed enrollment in the First-In-Human (FIH) CMIC-III study to evaluate the safety of a new less invasive approach to implanting the Cardiac Microcurrent (CMIC) device. Topline data are expected in 2026 and will be submitted for presentation at a major Cardiology Congress.

Oct. 8, 2025 — Viz.ai recently launched  Viz ACS, a new solution in the Viz Cardio Suite. Designed to unite the acute coronary syndrome (ACS) care team on a single platform, Viz ACS provides Emergency Department (ED) physicians and cardiologists with the same high-quality ECGs and patient data in real time. This streamlined workflow can help improve communication, speeds treatment, and reduces unnecessary cath lab activations.

Oct. 7, 2025 — RSNA Ventures, a mission-aligned subsidiary of Radiological Society of North America (RSNA), has announced a strategic partnership with Rad AI, the leader in generative AI for healthcare, to advance innovation in radiology and imaging technologies.

Oct. 7, 2025 — Cagent Vascular has announced the commercial launch of the Serranator PTA Serration Balloon Catheter in 7.0 mm and 8.0 mm diameters. This expansion brings the proven benefits of serration technology to larger vessels, including the iliac, SFA and other challenging peripheral anatomies.

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a successful limited market distribution. This milestone follows the announcement earlier this year of its exclusive U.S. distribution agreement with Raleigh, North Carolina-based Contego Medical.

Oct. 7, 2025 — Nobles Medical Technology II, a provider of  cardiovascular closure solutions, has announced that the U.S. Food and Drug Administration (FDA) has granted approval to restart its NobleStitch clinical trial, marking an important milestone in the development of the first device-free, suture-mediated system for closing patent formaen ovale (PFO) for reduction of recurrent cryptogenic stroke.

Oct. 2, 2025 — AorticLab recently announced the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) for the FLOWer System pivotal clinical investigation. The FLOWer System is an innovative full-body embolic protection device designed for use during transcatheter intracardiac procedures. Since obtainment of the CE mark under MDR in Q1 2024, FLOWer has been successfully utilized in very complex procedures, in several EU countries.

Sept. 26, 2025 — A new guideline from the American Society of Echocardiography (ASE) offers updated and expanded recommendations aimed at improving the quality, clarity and consistency of echocardiography reports across diverse clinical settings.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now